2019 Q1 Form 10-K Financial Statement
#000161883519000031 Filed on March 01, 2019
Income Statement
Concept | 2019 Q1 | 2018 Q4 | 2018 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $5.743M | $5.210M | $34.23M |
YoY Change | -36.4% | 157.92% | 461.15% |
% of Gross Profit | |||
Research & Development | $7.889M | $9.770M | $43.42M |
YoY Change | -34.03% | 2691.43% | 84.44% |
% of Gross Profit | |||
Depreciation & Amortization | $70.00K | $60.00K | $260.0K |
YoY Change | 0.0% | 200.0% | 420.0% |
% of Gross Profit | |||
Operating Expenses | $13.63M | $14.98M | $77.64M |
YoY Change | -35.04% | -2.38% | 117.56% |
Operating Profit | -$13.63M | -$77.64M | |
YoY Change | -35.04% | 117.56% | |
Interest Expense | -$4.420M | $30.00K | $130.0K |
YoY Change | -14833.33% | 200.0% | 160.0% |
% of Operating Profit | |||
Other Income/Expense, Net | -$4.436M | $0.00 | -$48.07M |
YoY Change | -90.77% | -100.0% | -30.95% |
Pretax Income | -$18.07M | -$14.98M | -$125.7M |
YoY Change | -73.84% | 534.75% | 19.38% |
Income Tax | $0.00 | $0.00 | $2.000K |
% Of Pretax Income | |||
Net Earnings | -$18.07M | -$14.98M | -$125.7M |
YoY Change | -73.84% | -23.15% | 19.38% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$672.2K | -$579.3K | -$5.740M |
COMMON SHARES | |||
Basic Shares Outstanding | 28.16M shares | 25.87M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2019 Q1 | 2018 Q4 | 2018 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $200.0K | $1.300M | $1.300M |
YoY Change | -96.0% | -61.76% | -61.76% |
Cash & Equivalents | $184.0K | $1.330M | $1.300M |
Short-Term Investments | |||
Other Short-Term Assets | $1.000M | $700.0K | $700.0K |
YoY Change | -54.55% | 16.67% | 16.67% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $1.413M | $2.478M | $2.500M |
YoY Change | -80.39% | 5.27% | -37.5% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $527.0K | $593.0K | $600.0K |
YoY Change | -32.69% | -30.07% | |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $649.0K | $939.0K | $400.0K |
YoY Change | -35.29% | 25.2% | 300.0% |
Total Long-Term Assets | $1.821M | $1.532M | $1.500M |
YoY Change | 1.96% | -4.13% | 1400.0% |
TOTAL ASSETS | |||
Total Short-Term Assets | $1.413M | $2.478M | $2.500M |
Total Long-Term Assets | $1.821M | $1.532M | $1.500M |
Total Assets | $3.234M | $4.010M | $4.000M |
YoY Change | -64.03% | 1.47% | -2.44% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $11.93M | $8.882M | $8.900M |
YoY Change | -10.34% | -1.3% | 1383.33% |
Accrued Expenses | $11.65M | $11.51M | $14.40M |
YoY Change | -7.48% | -4.74% | 1700.0% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $4.000M | $4.000M | $4.000M |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $32.09M | $27.33M | $27.30M |
YoY Change | 18.68% | -73.56% | 1850.0% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $32.09M | $27.33M | $27.30M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $32.09M | $27.37M | $27.40M |
YoY Change | 17.6% | -73.59% | 1857.14% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$451.2M | -$433.1M | |
YoY Change | 19.84% | 40.96% | |
Common Stock | $422.4M | $409.8M | |
YoY Change | 17.91% | 2211.15% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$28.85M | -$23.36M | -$23.40M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $3.234M | $4.010M | $4.000M |
YoY Change | -64.03% | 1.47% | -2.44% |
Cashflow Statement
Concept | 2019 Q1 | 2018 Q4 | 2018 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$18.07M | -$14.98M | -$125.7M |
YoY Change | -73.84% | -23.15% | 19.38% |
Depreciation, Depletion And Amortization | $70.00K | $60.00K | $260.0K |
YoY Change | 0.0% | 200.0% | 420.0% |
Cash From Operating Activities | -$7.678M | -$10.25M | -$56.50M |
YoY Change | -57.67% | 334.32% | 589.02% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$10.00K | $7.000K | |
YoY Change | 16.67% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $250.0K | $0.00 | $2.150M |
YoY Change | -88.37% | 21400.0% | |
Cash From Investing Activities | $250.0K | -$10.00K | $2.143M |
YoY Change | -88.37% | 21330.0% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | $200.0K | $200.0K | |
YoY Change | 0.0% | ||
Common Stock Issuance & Retirement, Net | $20.00M | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $6.267M | -500.0K | $54.42M |
YoY Change | -68.48% | -1766.67% | 181290.0% |
NET CHANGE | |||
Cash From Operating Activities | -$7.678M | -10.25M | -$56.50M |
Cash From Investing Activities | $250.0K | -10.00K | $2.143M |
Cash From Financing Activities | $6.267M | -500.0K | $54.42M |
Net Change In Cash | -$1.161M | -10.76M | $60.00K |
YoY Change | -129.79% | 361.8% | -100.74% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$7.678M | -$10.25M | -$56.50M |
Capital Expenditures | -$10.00K | $7.000K | |
Free Cash Flow | -$10.24M | -$56.51M | |
YoY Change | 333.9% | 588.61% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2018Q4 | evfm |
Unrecognized Stock Based Compensation Expense
UnrecognizedStockBasedCompensationExpense
|
5100000 | USD |
CY2018 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2018 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2018 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2018 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | |
CY2018 | dei |
Entity Registrant Name
EntityRegistrantName
|
EVOFEM BIOSCIENCES, INC. | |
CY2018 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-12-31 | |
CY2018 | dei |
Document Type
DocumentType
|
10-K | |
CY2018 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001618835 | |
CY2019Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
28156567 | shares |
CY2017Q1 | evfm |
Early Lease Termination Fees
EarlyLeaseTerminationFees
|
55000 | USD |
CY2017 | evfm |
Effective Income Tax Rate Reconciliation Accrual Of Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationAccrualOfUncertainTaxPositions
|
-0.0034 | |
CY2018 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2018 | evfm |
Effective Income Tax Rate Reconciliation Accrual Of Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationAccrualOfUncertainTaxPositions
|
-0.0057 | |
CY2018 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2018Q2 | dei |
Entity Public Float
EntityPublicFloat
|
16035680 | USD |
CY2017 | evfm |
Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantsPercent
|
-0.1975 | |
CY2018 | evfm |
Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantsPercent
|
-0.0002 | |
CY2016Q3 | evfm |
Disposal Group Including Discontinued Operation Consideration Receivable Stated Rate
DisposalGroupIncludingDiscontinuedOperationConsiderationReceivableStatedRate
|
0.05 | |
CY2018 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2018 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2017Q4 | evfm |
Accrued Clinical Studies Current
AccruedClinicalStudiesCurrent
|
8789000 | USD |
CY2018Q4 | evfm |
Accrued Clinical Studies Current
AccruedClinicalStudiesCurrent
|
9153000 | USD |
CY2017Q4 | evfm |
Accrued Deferred Offering Costs Current
AccruedDeferredOfferingCostsCurrent
|
135000 | USD |
CY2018Q4 | evfm |
Accrued Deferred Offering Costs Current
AccruedDeferredOfferingCostsCurrent
|
127000 | USD |
CY2017Q4 | evfm |
Accrued Directors Fees And Related Expenses Current
AccruedDirectorsFeesAndRelatedExpensesCurrent
|
247000 | USD |
CY2018Q4 | evfm |
Accrued Directors Fees And Related Expenses Current
AccruedDirectorsFeesAndRelatedExpensesCurrent
|
67000 | USD |
CY2017Q4 | evfm |
Accrued Franchise Tax
AccruedFranchiseTax
|
12000 | USD |
CY2018Q4 | evfm |
Accrued Franchise Tax
AccruedFranchiseTax
|
188000 | USD |
CY2017Q4 | evfm |
Accrued Interest Unpaid Sublicense Fees
AccruedInterestUnpaidSublicenseFees
|
76000 | USD |
CY2018Q4 | evfm |
Accrued Interest Unpaid Sublicense Fees
AccruedInterestUnpaidSublicenseFees
|
174000 | USD |
CY2017Q4 | evfm |
Accrued Sublicense Fees
AccruedSublicenseFees
|
2000000 | USD |
CY2018Q4 | evfm |
Accrued Sublicense Fees
AccruedSublicenseFees
|
1117000 | USD |
CY2018Q2 | evfm |
Class Of Warrant Or Right Issued In Transaction
ClassOfWarrantOrRightIssuedInTransaction
|
8500000 | shares |
CY2018Q4 | evfm |
Common Stock Reserved Upon Exercise Of Common Stock Warrants
CommonStockReservedUponExerciseOfCommonStockWarrants
|
4775886 | shares |
CY2018 | evfm |
Deemed Contribution Upon Exchange Of Preferred Stock
DeemedContributionUponExchangeOfPreferredStock
|
49334000 | USD |
CY2017 | evfm |
Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
|
137000 | USD |
CY2018 | evfm |
Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
|
94000 | USD |
CY2017 | evfm |
Deferred Rent Adjustment
DeferredRentAdjustment
|
30000 | USD |
CY2018 | evfm |
Deferred Rent Adjustment
DeferredRentAdjustment
|
242000 | USD |
CY2016Q3 | evfm |
Disposal Group Including Discontinued Operation Consideration Receivable Annual Principal Payment
DisposalGroupIncludingDiscontinuedOperationConsiderationReceivableAnnualPrincipalPayment
|
300000 | USD |
CY2017 | evfm |
Effective Income Tax Rate Reconciliation Deduction Loss On Issuance Of Warrants Percent
EffectiveIncomeTaxRateReconciliationDeductionLossOnIssuanceOfWarrantsPercent
|
0.0000 | |
CY2018 | evfm |
Effective Income Tax Rate Reconciliation Deduction Loss On Issuance Of Warrants Percent
EffectiveIncomeTaxRateReconciliationDeductionLossOnIssuanceOfWarrantsPercent
|
0.0801 | |
CY2017 | evfm |
Effective Income Tax Rate Reconciliation Provision To Return
EffectiveIncomeTaxRateReconciliationProvisionToReturn
|
0.0019 | |
CY2018 | evfm |
Effective Income Tax Rate Reconciliation Provision To Return
EffectiveIncomeTaxRateReconciliationProvisionToReturn
|
0.0003 | |
CY2017 | evfm |
Gain Loss On Issuance Of Convertible Preferred Stock
GainLossOnIssuanceOfConvertiblePreferredStock
|
-8522000 | USD |
CY2018 | evfm |
Gain Loss On Issuance Of Convertible Preferred Stock
GainLossOnIssuanceOfConvertiblePreferredStock
|
0 | USD |
CY2015Q1 | evfm |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P5Y | |
CY2017 | evfm |
Loss On Issuance Of Redeemable Convertible Preferred Stock And Related Warrants Net
LossOnIssuanceOfRedeemableConvertiblePreferredStockAndRelatedWarrantsNet
|
8522000 | USD |
CY2018 | evfm |
Loss On Issuance Of Redeemable Convertible Preferred Stock And Related Warrants Net
LossOnIssuanceOfRedeemableConvertiblePreferredStockAndRelatedWarrantsNet
|
0 | USD |
CY2017 | evfm |
Loss On Issuance Of Warrants
LossOnIssuanceOfWarrants
|
0 | USD |
CY2018 | evfm |
Loss On Issuance Of Warrants
LossOnIssuanceOfWarrants
|
47920000 | USD |
CY2018Q4 | evfm |
Notes Issued Stated Rate Monthly Percent Of Principal Permitted
NotesIssuedStatedRateMonthlyPercentOfPrincipalPermitted
|
0.01 | |
CY2015Q1 | evfm |
Operating Leases Number Of Renewal Options For Extended Terms
OperatingLeasesNumberOfRenewalOptionsForExtendedTerms
|
2 | renewal_term |
CY2017 | evfm |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
0 | USD |
CY2018 | evfm |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
37542000 | USD |
CY2014Q4 | evfm |
Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfAdditionalSharesAuthorized
|
0.010 | |
CY2017 | evfm |
Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit
|
18400000 | USD |
CY2018 | evfm |
Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit
|
200000 | USD |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8999000 | USD |
CY2018 | us-gaap |
Cash Acquired From Acquisition
CashAcquiredFromAcquisition
|
1900000 | USD |
CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8882000 | USD |
CY2017Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
12086000 | USD |
CY2018 | evfm |
Warrants And Stock Issued During Period Value New Issues
WarrantsAndStockIssuedDuringPeriodValueNewIssues
|
14062000 | USD |
CY2018 | evfm |
Weighted Average Remaining Period
WeightedAverageRemainingPeriod
|
P2Y2M26D | |
CY2018Q4 | evfm |
Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
|
-24900000 | USD |
CY2018Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
11513000 | USD |
CY2017Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
727000 | USD |
CY2018Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
549000 | USD |
CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
342000 | USD |
CY2018Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
604000 | USD |
CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
17731000 | USD |
CY2018Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
409787000 | USD |
CY2018 | us-gaap |
Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
|
-1592000 | USD |
CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
80000000 | USD |
CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
861000 | USD |
CY2018 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
17842000 | USD |
CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
861000 | USD |
CY2018 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
17842000 | USD |
CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8191028 | shares |
CY2018 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
10543513 | shares |
CY2017Q4 | us-gaap |
Assets
Assets
|
3952000 | USD |
CY2018Q4 | us-gaap |
Assets
Assets
|
4010000 | USD |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2354000 | USD |
CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2478000 | USD |
CY2018Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
904000 | USD |
CY2017 | us-gaap |
Cash Acquired From Acquisition
CashAcquiredFromAcquisition
|
0 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1211000 | USD |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1300000 | USD |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1330000 | USD |
CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1701000 | USD |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1761000 | USD |
CY2016Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
11487000 | USD |
CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1701000 | USD |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1761000 | USD |
CY2017 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-9786000 | USD |
CY2018 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
60000 | USD |
CY2018Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
6.23 | |
CY2018Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
2000000 | shares |
CY2018Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
11875 | shares |
CY2018Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
4775886 | shares |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2018Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2018Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
10892432 | shares |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2018Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
4051137 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2018Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
300000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2082053 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
25867248 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2082053 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
25867248 | shares |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
0 | USD |
CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
3000 | USD |
CY2017Q4 | us-gaap |
Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
|
80 | shares |
CY2017 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
CY2018 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
CY2017 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | USD |
CY2018 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | USD |
CY2017 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
3000 | USD |
CY2018 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
2000 | USD |
CY2017 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
3000 | USD |
CY2018 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
2000 | USD |
CY2017 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | USD |
CY2018 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | USD |
CY2017Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
114000 | USD |
CY2018Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
37000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
|
42281000 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
|
53933000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
89000 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
672000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
48418000 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
65205000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
3808000 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
5948000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
846000 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
747000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
1394000 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
3905000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
48418000 | USD |
CY2018Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
65205000 | USD |
CY2017 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
100000 | USD |
CY2018 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
100000 | USD |
CY2018 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.030 | |
CY2017 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
244000 | USD |
CY2018 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
262000 | USD |
CY2017 | us-gaap |
Depreciation Nonproduction
DepreciationNonproduction
|
200000 | USD |
CY2018 | us-gaap |
Depreciation Nonproduction
DepreciationNonproduction
|
300000 | USD |
CY2017Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
79870000 | USD |
CY2018Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
0 | USD |
CY2016Q3 | us-gaap |
Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
|
1300000 | USD |
CY2016Q3 | us-gaap |
Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
|
1900000 | USD |
CY2017Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
5200000 | USD |
CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-3.14 | |
CY2017Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-3.78 | |
CY2017Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-38.31 | |
CY2017Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-10.55 | |
CY2017 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-55.78 | |
CY2018Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-4.62 | |
CY2018Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.11 | |
CY2018Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.71 | |
CY2018Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.58 | |
CY2018 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-5.74 | |
CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
CY2018 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.1057 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.1283 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.0003 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.0001 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.0046 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.0056 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.0293 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
0.0103 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.2226 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.0019 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.0034 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.0021 | |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.0135 | |
CY2018 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.0160 | |
CY2017Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2392000 | USD |
CY2018Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2924000 | USD |
CY2017 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
12148000 | USD |
CY2018 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
34227000 | USD |
CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-105222000 | USD |
CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-125670000 | USD |
CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-105302000 | USD |
CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-125710000 | USD |
CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-80000 | USD |
CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-40000 | USD |
CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-105302000 | USD |
CY2018 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-125710000 | USD |
CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3000 | USD |
CY2017 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
7052000 | USD |
CY2018 | us-gaap |
Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
|
-130000 | USD |
CY2017Q4 | us-gaap |
Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
|
78870000 | USD |
CY2017Q4 | us-gaap |
Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
|
0 | claim |
CY2018Q4 | us-gaap |
Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
|
0 | claim |
CY2018 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2000 | USD |
CY2017 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
3000 | USD |
CY2018 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
2000 | USD |
CY2018 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
3799000 | USD |
CY2017 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
7319000 | USD |
CY2018 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-795000 | USD |
CY2017 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
775000 | USD |
CY2018 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
307000 | USD |
CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-145000 | USD |
CY2018 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
11000 | USD |
CY2017 | us-gaap |
Interest Paid Net
InterestPaidNet
|
15000 | USD |
CY2018 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
CY2017 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
128000 | USD |
CY2018 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
127000 | USD |
CY2017 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
500000 | USD |
CY2018 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
600000 | USD |
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
103627000 | USD |
CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
27366000 | USD |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3952000 | USD |
CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4010000 | USD |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
103347000 | USD |
CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
27329000 | USD |
CY2017 | us-gaap |
Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
|
-61175000 | USD |
CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
9212000 | USD |
CY2018 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
54417000 | USD |
CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
244000 | USD |
CY2018 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
2143000 | USD |
CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-19242000 | USD |
CY2018 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-56500000 | USD |
CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5269000 | USD |
CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6512000 | USD |
CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-74031000 | USD |
CY2017Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-19493000 | USD |
CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-105305000 | USD |
CY2018Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-69056000 | USD |
CY2018Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-23244000 | USD |
CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18431000 | USD |
CY2018Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-14981000 | USD |
CY2018 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-125712000 | USD |
CY2017Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-6157000 | USD |
CY2017 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-69615000 | USD |
CY2018Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
48070000 | USD |
CY2017Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
4147000 | USD |
CY2017Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7409000 | USD |
CY2017Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-75085000 | USD |
CY2017Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-20671000 | USD |
CY2017 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-109322000 | USD |
CY2018Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-69122000 | USD |
CY2018Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-23244000 | USD |
CY2018Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-18431000 | USD |
CY2018Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-14981000 | USD |
CY2018 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-125778000 | USD |
CY2017 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
|
0 | USD |
CY2018 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
|
46000 | USD |
CY2017Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
353000 | USD |
CY2017Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
154000 | USD |
CY2017Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
64961000 | USD |
CY2018Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
0 | USD |
CY2018Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2000 | USD |
CY2018Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
0 | USD |
CY2018 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-48068000 | USD |
CY2018Q4 | us-gaap |
Notes Issued1
NotesIssued1
|
4000000 | USD |
CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
100000 | USD |
CY2018Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
138000 | USD |
CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
750000 | USD |
CY2017 | us-gaap |
Notes Issued1
NotesIssued1
|
0 | USD |
CY2018 | us-gaap |
Notes Issued1
NotesIssued1
|
4010000 | USD |
CY2017Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
0 | USD |
CY2018Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
4010000 | USD |
CY2018 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | Segment |
CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
4913000 | USD |
CY2017Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
6358000 | USD |
CY2017Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
9070000 | USD |
CY2017Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
15346000 | USD |
CY2017 | us-gaap |
Operating Expenses
OperatingExpenses
|
35687000 | USD |
CY2018Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
20986000 | USD |
CY2018Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
23242000 | USD |
CY2018Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
18433000 | USD |
CY2018Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
14981000 | USD |
CY2018 | us-gaap |
Operating Expenses
OperatingExpenses
|
77642000 | USD |
CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-35687000 | USD |
CY2018 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-77642000 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
978000 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
777000 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
201000 | USD |
CY2018Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
939000 | USD |
CY2017Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
166000 | USD |
CY2018Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
0 | USD |
CY2017 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-46000 | USD |
CY2018 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-145000 | USD |
CY2017 | us-gaap |
Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
|
10665000 | USD |
CY2018 | us-gaap |
Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
|
0 | USD |
CY2018 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
200000 | USD |
CY2017 | us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
0 | USD |
CY2018 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1418000 | USD |
CY2018 | us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
157000 | USD |
CY2018Q2 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1500000 | USD |
CY2017 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
713000 | USD |
CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1190000 | USD |
CY2018Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1197000 | USD |
CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
848000 | USD |
CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
593000 | USD |
CY2018Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
431000 | USD |
CY2017 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | USD |
CY2018 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
42000 | USD |
CY2017 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | USD |
CY2018 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1592000 | USD |
CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
6000 | USD |
CY2018 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
7000 | USD |
CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
653000 | USD |
CY2018Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
717000 | USD |
CY2017 | us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
250000 | USD |
CY2018 | us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
250000 | USD |
CY2017 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2018 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
20000000 | USD |
CY2017 | us-gaap |
Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
|
9925000 | USD |
CY2018 | us-gaap |
Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
|
0 | USD |
CY2016Q3 | us-gaap |
Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
|
600000 | USD |
CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
23539000 | USD |
CY2018 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
43415000 | USD |
CY2017Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
490000 | USD |
CY2018Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
431000 | USD |
CY2017Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
490000 | USD |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-307277000 | USD |
CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-433100000 | USD |
CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-433146000 | USD |
CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
861000 | USD |
CY2018 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
17842000 | USD |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.000 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.000 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.909 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.870 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.022 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.029 | |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
|
0.15 | |
CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
28333 | shares |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | USD |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
12000 | USD |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
32.34 | |
CY2018 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.99 | |
CY2017Q4 | us-gaap |
Share Price
SharePrice
|
0.31 | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y10M25D | |
CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y6M | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
35520 | |
CY2018 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
4.58 | |
CY2017 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
0 | shares |
CY2018 | us-gaap |
Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
|
0 | shares |
CY2018 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
|
121315000 | USD |
CY2018 | us-gaap |
Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
|
5226000 | USD |
CY2018 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
42000 | USD |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-181085000 | USD |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-289546000 | USD |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-23356000 | USD |
CY2018 | us-gaap |
Stockholders Equity Change In Reporting Entity
StockholdersEquityChangeInReportingEntity
|
1946000 | USD |
CY2018Q1 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
166.7000 | |
CY2017 | us-gaap |
Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
|
4017000 | USD |
CY2018 | us-gaap |
Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
|
223000 | USD |
CY2017 | us-gaap |
Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
|
4017000 | USD |
CY2018 | us-gaap |
Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
|
66000 | USD |
CY2016Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
970000 | USD |
CY2017Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1335000 | USD |
CY2018Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
2061000 | USD |
CY2017 | us-gaap |
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
|
5000 | USD |
CY2017 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
370000 | USD |
CY2018 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
|
564000 | USD |
CY2018 | us-gaap |
Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
|
162000 | USD |
CY2017 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
0 | USD |
CY2018 | us-gaap |
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
|
0 | USD |
CY2018Q1 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
14100000 | USD |
CY2017 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
1959904 | shares |
CY2018 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
21900574 | shares |
CY2018 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations of Credit Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and restricted cash. Deposits in the Company’s checking and time deposit accounts are maintained in federally insured financial institutions in excess of federally insured limits. The Company invests in funds through a major U.S. bank and is exposed to credit risk in the event of default to the extent of amounts recorded on the consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Company has not experienced any losses in such accounts and believes it is not exposed to significant concentrations of credit risk on its cash, cash equivalents and restricted cash balances due to the financial position of the depository institutions in which these deposits are held.</font></div></div> | |
CY2018 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and the notes thereto. </font><font style="font-family:inherit;font-size:9pt;">S</font><font style="font-family:inherit;font-size:10pt;">ignificant estimates affecting amounts reported or disclosed in the consolidated financial statements include, but not limited to, the measurement of the Series D 2X liquidation preference, assumptions used in estimating the fair value of warrants issued in connection with the Merger, the useful lives of property and equipment, the recoverability of long-lived assets, preclinical and clinical trial accruals, assumptions used in estimating the fair value of stock-based compensation expense and other contingencies. The Company’s assumptions regarding the measurement of the Series D 2X liquidation preference and stock-based compensation are more fully described in </font><a style="font-family:inherit;font-size:10pt;" href="#s9C2FC6E1ACE55EA3BBF27A8B12AEF064"><font style="font-family:inherit;font-size:10pt;">Note 5 — Fair Value of Financial Instruments</font></a><font style="font-family:inherit;font-size:10pt;"> and </font><a style="font-family:inherit;font-size:10pt;" href="#s319B0DA926A350D2A840F986C95DB4BA"><font style="font-family:inherit;font-size:10pt;">Note 11 — Stock-based Compensation, </font></a><font style="font-family:inherit;font-size:10pt;">respectively. The Company bases its estimates on historical experience and other market-specific or other relevant assumptions that it believes to be reasonable under the circumstances and adjusts when facts and circumstances dictate. The estimates are the basis for making judgments about the carrying values of assets and liabilities and recorded expenses that are not readily apparent from other sources. As future events and their effects cannot be determined with precision, actual results may materially differ from those estimates or assumptions.</font></div></div> |